1. Sebaceous Gland Carcinoma
- Author
-
Poh Sun Goh, Stephanie Ming Young, Min En Nga, Bingcheng Wu, Gangadhara Sundar, and Shantha Amrith
- Subjects
Lid margin ,medicine.medical_specialty ,business.industry ,Meibomian gland ,medicine.disease ,Dermatology ,body regions ,medicine.anatomical_structure ,Chalazion ,Medicine ,sense organs ,Sebaceous gland carcinoma ,Thickening ,Eyelid ,business - Abstract
Sebaceous gland carcinoma (SGC) of the eyelid is usually considered a rare tumour (1–5% of all cutaneous malignancies in the USA), but higher incidence rates have been seen in Asia (28–60%). It has a tendency for intraepithelial spread, as well as regional and distant metastases. Early diagnosis and timely management can help reduce morbidity and mortality. In the eyelids, it may arise from meibomian glands (most common), glands of Zeis or sebaceous glands associated with the caruncle. It is two to three times more common in the upper lids due to the higher number of meibomian glands. Any unilateral blepharoconjunctivitis with loss of eyelashes and thickening of lid margin that fails to respond to treatment should be biopsied, and so should an atypical or recurrent chalazion.
- Published
- 2019